A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
Clinical trial NCT06340854 · COMPLETED
Trial details
- NCT number
- NCT06340854
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-19
- Primary completion
- 2025-05-08
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.